A Novartis experimental drug in clinical trial aims to block liver cancer growth

An interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases.

The Novartis Faculty of Scholars initiative connects academic researchers with deep knowledge and big ideas to scientists in its drug discovery labs.

Kristen Harrington-Smith discusses her work as Vice President and Head of CAR-T US at Novartis Oncology.

Team uncovers a potential therapeutic approach for patients deficient in a protein called Shank3.

The modernization and miniaturization of pharmaceutical production could expand the range of ingredients medicinal chemists use to make new drugs.

Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.

Using new technologies, researchers have developed a deeper understanding of how cells function, changing conceptions of disease.